Acute abdominal compartment syndrome (ACS) is a life-threatening condition characterized by increased intra-abdominal pressure (IAP) leading to end-organ dysfunction. Prompt recognition and timely surgical intervention are critical for patient survival. This review synthesizes current evidence on the surgical management of ACS, integrating recent advances, clinical insights, and guideline-based recommendations for healthcare professionals.
Acute abdominal compartment syndrome, though relatively rare, represents a surgical emergency where delayed diagnosis or inappropriate management can result in significant morbidity and mortality. The syndrome is defined by a sustained increase in IAP (usually >20 mmHg) associated with new organ dysfunction. The clinical approach to ACS has evolved, with emphasis now on early detection, decompressive strategies, and comprehensive perioperative care. This article provides an evidence-based overview of the epidemiology, pathophysiology, clinical presentation, and modern surgical management of ACS, with a focus on current guidelines and practical considerations.
ACS most frequently occurs in critically ill patients, notably those with severe trauma, major abdominal surgery, massive fluid resuscitation, or sepsis. Reported incidence varies between 1-14% in intensive care cohorts, with higher rates in specific populations such as burn victims and those with severe pancreatitis. Mortality rates remain high, historically exceeding 50%, though improved recognition and management have contributed to declining trends in recent years. The true burden of ACS is likely underestimated due to challenges in diagnosis and underreporting.
The pathophysiology of ACS is rooted in sustained elevation of IAP, which impairs venous return, compromises cardiac output, reduces splanchnic perfusion, and restricts diaphragmatic excursion. These changes precipitate multi-organ dysfunction, including acute kidney injury, respiratory compromise, and gastrointestinal ischemia. Vicious cycles may ensue as reduced perfusion leads to capillary leak and further fluid accumulation, perpetuating the compartment syndrome. Understanding these mechanisms is pivotal for timely intervention and guides the rationale for surgical decompression.
Key risk factors for the development of ACS include massive fluid resuscitation, abdominal trauma, intra-abdominal hemorrhage, sepsis, pancreatitis, visceral edema, and retroperitoneal hematoma. Additional contributors are mechanical ventilation with high positive end-expiratory pressure (PEEP), obesity, pregnancy, and conditions causing increased intra-abdominal volume. Identification of high-risk patients is essential for targeted monitoring and prophylactic interventions.
ACS presents with a constellation of signs and symptoms reflecting rising IAP and organ dysfunction. Common features include tense, distended abdomen, oliguria or anuria, hypotension, tachycardia, increased airway pressures, hypoxemia, and metabolic acidosis. Clinical suspicion should be heightened in at-risk patients who deteriorate despite resuscitative measures. The non-specific nature of symptoms underscores the importance of objective measurement of IAP.
Diagnosis of ACS is based on the World Society of the Abdominal Compartment Syndrome (WSACS) criteria: sustained IAP >20 mmHg with new organ dysfunction. IAP is most reliably measured via bladder pressure using a Foley catheter. Serial assessments are recommended, especially in high-risk patients. Adjunctive imaging (ultrasound, CT) can aid in identifying intra-abdominal pathology or compartmentalized fluid collections but should not delay intervention in unstable patients.
Initial management aims to reduce IAP by non-surgical means: optimizing fluid balance, evacuating intraluminal contents (nasogastric or rectal decompression), improving abdominal wall compliance (sedation, neuromuscular blockade), and correcting positive fluid balance. If these measures fail or if ACS is rapidly evolving with refractory organ dysfunction, surgical decompressive laparotomy is indicated. The procedure involves midline laparotomy with evacuation of intra-abdominal contents and temporary abdominal closure, typically using negative pressure wound therapy. Postoperatively, meticulous fluid management, infection control, and staged abdominal wall reconstruction are necessary. Early surgical intervention has been associated with improved survival and organ recovery.
Recent advances in ACS management include the use of minimally invasive decompression techniques, improved negative pressure abdominal dressings, and enhanced protocols for staged abdominal closure. Pharmacological strategies to reduce capillary leak and inflammation are under investigation. Enhanced critical care monitoring, including continuous IAP measurement and point-of-care ultrasonography, facilitates earlier detection and intervention. The integration of multidisciplinary teams, including surgeons, intensivists, and wound care specialists, has improved outcomes in complex cases.
Current WSACS guidelines emphasize early recognition, routine IAP monitoring in high-risk patients, and a stepwise approach to management beginning with non-operative interventions and progressing to surgical decompression when warranted. Timely decompressive laparotomy is advocated for patients with refractory ACS and new-onset organ dysfunction. Temporary abdominal closure is recommended post-decompression, with planned re-exploration and delayed definitive closure. Multidisciplinary coordination and adherence to evidence-based protocols are critical for optimizing outcomes.
Acute abdominal compartment syndrome remains a formidable challenge in critical care and surgical practice. Early diagnosis, aggressive supportive care, and timely surgical intervention are paramount to improving patient survival. Recent advances in surgical techniques, monitoring, and perioperative management have contributed to better outcomes, but continued vigilance and adherence to guideline-based strategies are essential. Further research into less invasive therapies and optimized protocols holds promise for reducing the burden of ACS in the future.
1.
Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.
2.
Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.
3.
Revolutionary Cancer Tx Could Transform Autoimmune Disease
4.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
5.
Cardiomyocytes are shielded from chemotherapy damage by mitochondrial proteins.
1.
Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment
2.
AI and Optical Advances: Evolving Blood Cell Morphology Observation in Hematology
3.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
4.
Quality of Life Optimization in Long-Term Cancer Survivorship
5.
Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Lung Cancer: Risk Factors and Prevention
2.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
3.
Navigating the Complexities of Ph Negative ALL - Part VIII
4.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation